|
1
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansen J: Increased breast cancer risk
among women who work predominantly at night. Epidemiology.
12:74–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kloog I, Haim A, Stevens RG and Portnov
BA: Global co-distribution of light at night (LAN) and cancers of
prostate, colon, and lung in men. Chronobiol Int. 26:108–125. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viswanathan AN, Hankinson SE and
Schernhammer ES: Night shift work and the risk of endometrial
cancer. Cancer Res. 67:10618–10622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bass J and Takahashi JS: Circadian
integration of metabolism and energetics. Science. 330:1349–1354.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masri S, Papagiannakopoulos T, Kinouchi K,
Liu Y, Cervantes M, Baldi P, Jacks T and Sassone-Corsi P: Lung
adenocarcinoma distally rewires hepatic circadian homeostasis.
Cell. 165:896–909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Puram RV, Kowalczyk MS, de Boer CG,
Schneider RK, Miller PG, McConkey M, Tothova Z, Tejero H, Heckl D,
Järås M, et al: Core circadian clock genes regulate leukemia stem
cells in AML. Cell. 165:303–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Dycke KC, Rodenburg W, van Oostrom CT,
van Kerkhof LW, Pennings JL, Roenneberg T, van Steeg H and van der
Horst GT: Chronically alternating light cycles increase breast
cancer risk in mice. Curr Biol. 25:1932–1937. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reppert SM and Weaver DR: Coordination of
circadian timing in mammals. Nature. 418:935–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schibler U and Sassone-Corsi P: A web of
circadian pacemakers. Cell. 111:919–922. 2002. View Article : Google Scholar
|
|
13
|
Li A, Lin X, Tan X, Yin B, Han W, Zhao J,
Yuan J, Qiang B and Peng X: Circadian gene Clock contributes to
cell proliferation and migration of glioma and is directly
regulated by tumor-suppressive miR-124. FEBS Lett. 587:2455–2460.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ghotra VP, Puigvert JC and Danen EH: The
cancer stem cell microenvironment and anti-cancer therapy. Int J
Radiat Biol. 85:955–962. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Florian S, Sonneck K, Hauswirth AW, Krauth
MT, Schernthaner GH, Sperr WR and Valent P: Detection of molecular
targets on the surface of CD34+/CD38-stem cells in various myeloid
malignancies. Leuk Lymphoma. 47:207–222. 2006. View Article : Google Scholar
|
|
17
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsunaga N, Ogino T, Hara Y, Tanaka T,
Koyanagi S and Ohdo S: Optimized dosing schedule based on circadian
dynamics of mouse breast cancer stem cells improves the antitumor
effects of aldehyde dehydrogenase inhibitor. Cancer Res.
78:3698–3708. 2018.PubMed/NCBI
|
|
19
|
Dong Z, Zhang G, Qu M, Gimple RC, Wu Q,
Qiu Z, Prager BC, Wang X, Kim LJY, Morton AR, et al: Targeting
glioblastoma stem cells through disruption of the circadian clock.
Cancer Discov. 9:1556–1573. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Zhang DG, Jiang AG, Lu HY, Zhang LX and
Gao XY: Isolation, cultivation and identification of human lung
adenocarcinoma stem cells. Oncol Lett. 9:47–54. 2015. View Article : Google Scholar
|
|
22
|
Nguyen LV, Vanner R, Dirks P and Eaves CJ:
Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–13.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leon G, MacDonagh L, Finn SP, Cuffe S and
Barr MP: Cancer stem cells in drug resistant lung cancer: Targeting
cell surface markers and signaling pathways. Pharmacol Ther.
158:71–90. 2016. View Article : Google Scholar
|
|
24
|
Suresh R, Ali S, Ahmad A, Philip PA and
Sarkar FH: The role of cancer stem cells in recurrent and
drug-resistant lung cancer. Adv Exp Med Biol. 890:57–74. 2016.
View Article : Google Scholar
|
|
25
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–114. 2008.
View Article : Google Scholar
|
|
26
|
Dierickx P, Van Laake LW and Geijsen N:
Circadian clocks: From stem cells to tissue homeostasis and
regeneration. EMBO Rep. 19:18–28. 2018. View Article : Google Scholar :
|
|
27
|
Zhang F, Sun H, Zhang S, Yang X, Zhang G
and Su T: Overexpression of PER3 inhibits self-renewal capability
and chemoresistance of colorectal cancer stem-like cells via
inhibition of notch and β-catenin signaling. Oncol Res. 25:709–719.
2017. View Article : Google Scholar
|
|
28
|
Okazaki F, Matsunaga N, Okazaki H, Azuma
H, Hamamura K, Tsuruta A, Tsurudome Y, Ogino T, Hara Y, Suzuki T,
et al: Circadian clock in a mouse colon tumor regulates
intracellular iron levels to promote tumor progression. J Biol
Chem. 291:7017–1028. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun Y, Jin L, Sui YX, Han LL and Liu JH:
Circadian gene CLOCK affects drug-resistant gene expression and
cell proliferation in ovarian cancer SKOV3/DDP cell lines through
autophagy. Cancer Biother Radiopharm. 32:139–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zaveri NT: Green tea and its polyphenolic
catechins: Medicinal uses in cancer and noncancer applications.
Life sci. 78:2073–2080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kweon MH, Adhami VM, Lee JS and Mukhtar H:
Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in
A549 cells contributes to resistance to apoptosis induced by
epigallocatechin 3-gallate. J Biol Chem. 281:33761–33772. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou
M, Haq IU, Mariyam Z and Feng Q: Epigallocatechin-3-gallate
inhibited cancer stem cell-like properties by targeting
hsa-mir-485-5p/RXRα in lung cancer. J Cell Biochem. 119:8623–8635.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang P, Xu C, Chen L, Chen A, Wu X, Zhou
M, Haq IU, Mariyam Z and Feng Q: EGCG inhibits CSC-like properties
through targeting miR-485/CD44 axis in A549-cisplatin resistant
cells. Mol Carcinog. 57:1835–1844. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jang GB, Kim JY, Cho SD, Park KS, Jung JY,
Lee HY, Hong IS and Nam JS: Blockade of Wnt/β-catenin signaling
suppresses breast cancer metastasis by inhibiting CSC-like
phenotype. Sci Rep. 5:124652015. View Article : Google Scholar
|
|
35
|
Shapiro M, Akiri G, Chin C, Wisnivesky JP,
Beasley MB, Weiser TS, Swanson SJ and Aaronson SA: Wnt pathway
activation predicts increased risk of tumor recurrence in patients
with stage I nonsmall cell lung cancer. Ann Surg. 257:548–554.
2013. View Article : Google Scholar :
|
|
36
|
Jiang HL, Jiang LM and Han WD:
Wnt/β-catenin signaling pathway in lung cancer stem cells is a
potential target for the development of novel anticancer drugs. J
BUON. 20:1094–1100. 2015.PubMed/NCBI
|
|
37
|
Zhu J, Jiang Y, Yang X, Wang S, Xie C, Li
X, Li Y, Chen Y, Wang X, Meng Y, et al: Wnt/β-catenin pathway
mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung
cancer stem cells. Biochem Biophys Res Commun. 482:15–21. 2017.
View Article : Google Scholar
|
|
38
|
Zhang X, Lou Y, Zheng X, Wang H, Sun J,
Dong Q and Han B: Wnt blockers inhibit the proliferation of lung
cancer stem cells. Drug Des Devel Ther. 9:2399–2407.
2015.PubMed/NCBI
|
